Articles with "evaluation blood" as a keyword



Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live‐Cell Imaging Platform

Sign Up to like & get
recommendations!
Published in 2025 at "Cytometry Part A"

DOI: 10.1002/cyto.a.24930

Abstract: Cellular cytotoxicity is an important mechanism of the immune system to clear infections and eliminate tumor cells. Its two main mediators are cytotoxic T lymphocytes and natural killer (NK) cells. In lung cancer, intratumoral NK… read more here.

Keywords: tumor cells; blood cytotoxicity; cytotoxicity; evaluation blood ... See more keywords

PS01.193: VISUALIZED EVALUATION OF BLOOD FLOW TO THE GASTRIC CONDUIT CONTRIBUTES TO REDUCTION OF COMPLICATION IN ESOPHAGEAL RECONSTRUCTION

Sign Up to like & get
recommendations!
Published in 2018 at "Diseases of the Esophagus"

DOI: 10.1093/dote/doy089.ps01.193

Abstract: Evaluation of the blood supply to gastric conduits is critically important to avoid complications following esophagectomy. We commenced visualized evaluation of blood flow using indocyanine green (ICG) fluorescent imaging from July 2015, to reduce reconstructive… read more here.

Keywords: blood flow; evaluation blood; evaluation; blood ... See more keywords

Retrospective Evaluation of Blood Product Transfusion Outcomes and Risk Factors for Transfusion Reactions in Dogs at a Veterinary Teaching Hospital With an Established Blood Bank: 137 Dogs (2018–2022)

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Veterinary Emergency and Critical Care"

DOI: 10.1111/vec.70034

Abstract: To evaluate the outcome of blood transfusions in dogs and identify the incidence of and risk factors associated with transfusion reactions (TRs) classified according to the Association of Veterinary Hematology and Transfusion Medicine (AVHTM) consensus. read more here.

Keywords: evaluation blood; transfusion reactions; retrospective evaluation; risk factors ... See more keywords
Photo by nci from unsplash

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.12001

Abstract: 12001Background: TMB in both tissue and blood has shown promise in selecting for patients (pts) who clinically benefit from PD-L1/PD-1 inhibitors. In the randomized, 2L NSCLC Phase III OAK and Phas... read more here.

Keywords: based tumor; evaluation blood; clinical evaluation; blood ... See more keywords
Photo by nci from unsplash

Evaluation of blood TMB (bTMB) in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) with pemetrexed and platinum versus placebo plus chemo as first-line therapy for metastatic nonsquamous NSCLC.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.9521

Abstract: 9521Background: In a previous analysis of KEYNOTE-189 (NCT02578680), we showed that tissue TMB (tTMB) assessed by whole-exome sequencing was not significantly associated with efficacy in either arm... read more here.

Keywords: chemo; evaluation blood; keynote 189; tmb btmb ... See more keywords
Photo by nci from unsplash

Evaluation of blood-based proteomic biomarkers associated with response to anti-PD-1 treatment in NSCLC.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.e21531

Abstract: e21531Background: Immune checkpoint inhibitors have remarkably improved the natural history of patients with non-small cell lung cancer (NSCLC), with improved clinical responses and overall surviva... read more here.

Keywords: associated response; based proteomic; evaluation blood; proteomic biomarkers ... See more keywords

Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus

Sign Up to like & get
recommendations!
Published in 2017 at "PLoS ONE"

DOI: 10.1371/journal.pone.0186414

Abstract: Although quotient of alpha2 macroglobulin (Qα2MG) was previously reported to be useful for the evaluation of blood–brain barrier (BBB) function, it is not commonly used. We therefore evaluated BBB function among the various subsets of… read more here.

Keywords: blood brain; alpha2 macroglobulin; evaluation blood; evaluation ... See more keywords